Nutrition supplement study for cystic fibrosis
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This study tests whether a special nutrition supplement can help people with cystic fibrosis who also have pancreatic problems. It is for adults 18 and older who are already taking a CFTR modulator and have normal liver lab results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cystic fibrosis
- You have exocrine pancreatic insufficiency (your pancreas doesn't make enough digestive enzymes)
- You are 18 years or older
- You are currently taking a CFTR modulator drug
- Your liver enzyme labs are normal
- You do not have a history of liver problems or take certain medications or supplements that could interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a Mediterranean-style diet can improve gastrointestinal health in children with cystic fibrosis. It requires families to follow the diet for 6 months and attend regular clinic visits.
This study tests whether people with cystic fibrosis who are already on a triple combination CFTR modulator can stay on their treatment without interruptions or problems. It aims to make sure everyone gets the best, most consistent treatment for their CF.
This trial tests how safe and tolerable three different study drugs (SION-451, SION-2222, and SION-109) are when taken together in healthy adults. The goal is to find a good dose combination for future studies in people with cystic fibrosis.
This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.
This study uses advanced diagnostic tests to help people whose cystic fibrosis (CF) diagnosis is unclear. It aims to give a clearer answer about whether you have CF or a related condition.
This study looks at how the body processes a mixed meal in people with cystic fibrosis who are on CFTR modulator therapy. It may help researchers understand how these medications change hormone and blood sugar responses.
Hear when a new Cystic Fibrosis (CF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.